Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in Prog Cardiovasc Dis Retrieve available abstracts of 65 articles: HTML format

Single Articles

April 2024
1. JAISWAL V, Sawhney A, Nebuwa C, Borra V, et al
   Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials.
   Prog Cardiovasc Dis. 2024 Apr 5:S0033-0620(24)00055.
   PubMed     Abstract available
   
   
   March 2024
2. TUTOR A, O'Keefe EL, Lavie CJ, Elagizi A, et al
   Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.
   Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00054.
   PubMed     Abstract available
   
   
   
3. LAKSHMANAN S, Wei J, Cook-Wiens G, Pepine CJ, et al
   Comparison of risk profiles of participants in the Women's IschemiA TRial to reduce events in non-ObstRuctive CAD (WARRIOR) trial, using coronary computed tomography angiography vs invasive coronary angiography.
   Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00053.
   PubMed     Abstract available
   
   
   
4. LIPPI G, Sanchis-Gomar F, Lavie CJ
   Excess mortality for acute myocardial infarction in the United States during the first two years of the COVID-19 pandemic.
   Prog Cardiovasc Dis. 2024 Mar 20:S0033-0620(24)00051.
   PubMed    
   
   
   February 2024
5. KRISHNAN S, Aldana-Bitar J, Golub I, Ichikawa K, et al
   Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men.
   Prog Cardiovasc Dis. 2024 Feb 27:S0033-0620(24)00036.
   PubMed     Abstract available
   
   
   January 2024
6. LAVIE CJ
   Over a decade as editor-in-chief at progress in cardiovascular diseases.
   Prog Cardiovasc Dis. 2024 Jan 24:S0033-0620(24)00019.
   PubMed    
   
   
   
7. GERSH F, O'Keefe JH, Elagizi A, Lavie CJ, et al
   Estrogen and cardiovascular disease.
   Prog Cardiovasc Dis. 2024 Jan 23:S0033-0620(24)00015.
   PubMed     Abstract available
   
   
   
8. ABDUL-RAHMAN T, Lizano-Jubert I, Bliss ZSB, Garg N, et al
   RNA in cardiovascular disease: A new frontier of personalized medicine.
   Prog Cardiovasc Dis. 2024 Jan 20:S0033-0620(24)00016.
   PubMed     Abstract available
   
   
   
9. AKHTAR KH, Khan MS, Baron SJ, Zieroth S, et al
   The spectrum of post-myocardial infarction care: From acute ischemia to heart failure.
   Prog Cardiovasc Dis. 2024 Jan 17:S0033-0620(24)00017.
   PubMed     Abstract available
   
   
   
10. LIPPI G, Mattiuzzi C, Sanchis-Gomar F
    The weekly mortality for ischemic heart disease in the US still peaks on mondays.
    Prog Cardiovasc Dis. 2024 Jan 12:S0033-0620(24)00007.
    PubMed    
    
    
    October 2023
11. ROZANSKI A, Han D, Miller RJH, Gransar H, et al
    Comparison of coronary artery calcium scores among patients referred for cardiac imaging tests.
    Prog Cardiovasc Dis. 2023 Oct 17:S0033-0620(23)00108.
    PubMed     Abstract available
    
    
    
12. CILIBERTI G, Guerra F, Pizzi C, Merlo M, et al
    Characteristics of patients with recurrent acute myocardial infarction after MINOCA.
    Prog Cardiovasc Dis. 2023 Oct 16:S0033-0620(23)00109.
    PubMed     Abstract available
    
    
    July 2023
13. KRITTANAWONG C, Isath A, Kaplin S, Virk HUH, et al
    Cardiovascular disease in space: A systematic review.
    Prog Cardiovasc Dis. 2023 Jul 31:S0033-0620(23)00075.
    PubMed     Abstract available
    
    
    
14. LAVIE CJ
    Cardiovascular statistics 2023.
    Prog Cardiovasc Dis. 2023 Jul 18:S0033-0620(23)00071.
    PubMed    
    
    
    
15. RAWAL H, Nakhle A, Peters M, Srivastav A, et al
    Incidence of acute myocardial infarction and hurricane Katrina: Fourteen years after the storm.
    Prog Cardiovasc Dis. 2023 Jul 5:S0033-0620(23)00067.
    PubMed     Abstract available
    
    
    June 2023
16. ABDUL-RAHMAN T, Lizano-Jubert I, Garg N, Talukder S, et al
    The common pathobiology between coronary artery disease and calcific aortic stenosis: Evidence and clinical implications.
    Prog Cardiovasc Dis. 2023 Jun 9:S0033-0620(23)00058.
    PubMed     Abstract available
    
    
    May 2023
17. NEELAND IJ
    Adipo-cardiology: The next frontier in cardiovascular disease.
    Prog Cardiovasc Dis. 2023 May 6:S0033-0620(23)00049.
    PubMed    
    
    
    April 2023
18. ISATH A, Koziol KJ, Martinez MW, Garber CE, et al
    Exercise and cardiovascular health: A state-of-the-art review.
    Prog Cardiovasc Dis. 2023 Apr 27:S0033-0620(23)00038.
    PubMed     Abstract available
    
    
    
19. IACOBELLIS G
    Epicardial fat links obesity to cardiovascular diseases.
    Prog Cardiovasc Dis. 2023 Apr 25:S0033-0620(23)00036.
    PubMed     Abstract available
    
    
    March 2023
20. KHAWAJA T, Linge J, Leinhard OD, Al-Kindi SG, et al
    Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
    Prog Cardiovasc Dis. 2023 Mar 15:S0033-0620(23)00027.
    PubMed     Abstract available
    
    
    
21. DI FUSCO SA, Aquilani S, Spinelli A, Alonzo A, et al
    The polypill strategy in cardiovascular disease prevention: It's time for its implementation.
    Prog Cardiovasc Dis. 2023 Mar 15:S0033-0620(23)00028.
    PubMed     Abstract available
    
    
    
22. BANACH M, Penson PE, Farnier M, Fras Z, et al
    Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the international lipid expert panel (ILEP).
    Prog Cardiovasc Dis. 2023 Mar 6:S0033-0620(23)00026.
    PubMed     Abstract available
    
    
    
23. ROZANSKI A, Sakul S, Narula J, Uretsky S, et al
    Assessment of lifestyle-related risk factors enhances the effectiveness of cardiac stress testing.
    Prog Cardiovasc Dis. 2023;77:95-106.
    PubMed     Abstract available
    
    
    February 2023
24. FIGUEIRO MG, Pedler D
    Cardiovascular disease and lifestyle choices: Spotlight on circadian rhythms and sleep.
    Prog Cardiovasc Dis. 2023 Feb 23:S0033-0620(23)00010.
    PubMed     Abstract available
    
    
    January 2023
25. FAGHY MA, Yates J, Hills AP, Jayasinghe S, et al
    Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective.
    Prog Cardiovasc Dis. 2023 Jan 21:S0033-0620(23)00002.
    PubMed     Abstract available
    
    
    
26. JOSEPHSON RA, Gillombardo CB
    Cardiovascular services in Covid-19 - Impact of the pandemic and lessons learned.
    Prog Cardiovasc Dis. 2023 Jan 20:S0033-0620(23)00005.
    PubMed     Abstract available
    
    
    
27. ASHTON RE, Philips BE, Faghy M
    The acute and chronic implications of the COVID-19 virus on the cardiovascular system in adults: A systematic review.
    Prog Cardiovasc Dis. 2023 Jan 20:S0033-0620(23)00004.
    PubMed     Abstract available
    
    
    
28. LAVIE CJ
    A decade as editor-in-chief of progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2023;76:118-119.
    PubMed    
    
    
    
29. HAJRA A, Malik A, Bandyopadhyay D, Goel A, et al
    Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis.
    Prog Cardiovasc Dis. 2023;76:25-30.
    PubMed     Abstract available
    
    
    December 2022
30. PRONK NP, Mabry PL, Bond S, Arena R, et al
    Systems science approaches to cardiovascular disease prevention and management in the era of COVID-19: A Humpty-Dumpty dilemma?
    Prog Cardiovasc Dis. 2022 Dec 20:S0033-0620(22)00155.
    PubMed     Abstract available
    
    
    
31. ARENA R, Faghy M, Laddu D
    A perpetual state of bad dreams: The prevention and management of cardiovascular disease in the COVID-19 pandemic era and beyond.
    Prog Cardiovasc Dis. 2022 Dec 15:S0033-0620(22)00156.
    PubMed    
    
    
    
32. MATSUSHITA K, Kojima S, Hirakawa K, Tabata N, et al
    Differential effects of overweight/obesity depending on the severity of heart failure complicating acute myocardial infarction in Japan.
    Prog Cardiovasc Dis. 2022 Dec 5:S0033-0620(22)00141.
    PubMed     Abstract available
    
    
    
33. TUTOR AW, Lavie CJ, Kachur S, Milani RV, et al
    Updates on obesity and the obesity paradox in cardiovascular diseases.
    Prog Cardiovasc Dis. 2022 Dec 5:S0033-0620(22)00134.
    PubMed     Abstract available
    
    
    
34. LADDU DR, Biggs E, Kaar J, Khadanga S, et al
    The impact of the COVID-19 pandemic on cardiovascular health behaviors and risk factors: A new troubling normal that may be here to stay.
    Prog Cardiovasc Dis. 2022 Dec 5:S0033-0620(22)00138.
    PubMed     Abstract available
    
    
    
35. FAGHY MA, Ashton REM, Parizher G, Smith A, et al
    COVID-19 and elite sport: Cardiovascular implications and return-to-play.
    Prog Cardiovasc Dis. 2022 Dec 1:S0033-0620(22)00135.
    PubMed     Abstract available
    
    
    November 2022
36. KRITTANAWONG C, Maitra NS, Khawaja M, Wang Z, et al
    Association of pessimism with cardiovascular events and all-cause mortality.
    Prog Cardiovasc Dis. 2022 Nov 30:S0033-0620(22)00139.
    PubMed     Abstract available
    
    
    
37. AL RIFAI M, Ahmed AI, Alahdab F, Al-Mallah MH, et al
    Clinical utility of coronary artery computed tomography angiography- What we know and What's new?
    Prog Cardiovasc Dis. 2022 Nov 3. pii: S0033-0620(22)00112.
    PubMed     Abstract available
    
    
    October 2022
38. ADABIFIROUZJAEI F, Kimura BJ, Khazai B, DeMaria AN, et al
    Handheld ultrasonography in cardiovascular medicine, updates and controversies.
    Prog Cardiovasc Dis. 2022 Oct 29:S0033-0620(22)00111.
    PubMed     Abstract available
    
    
    
39. VASUDEVA R, Challa A, Al Rifai M, Polana T, et al
    Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States.
    Prog Cardiovasc Dis. 2022 Oct 21. pii: S0033-0620(22)00098.
    PubMed     Abstract available
    
    
    September 2022
40. ROZANSKI A, Han D, Blaha MJ, Gransar H, et al
    Association between hypercholesterolemia and mortality risk among patients referred for cardiac imaging test: Evidence of a "cholesterol paradox?".
    Prog Cardiovasc Dis. 2022;74:60-69.
    PubMed     Abstract available
    
    
    
41. MITTAN S, Lee S, Mehra MR
    Artificial intelligence in cardiovascular disease: Challenges and benefits in developing nations.
    Prog Cardiovasc Dis. 2022;74:129-130.
    PubMed    
    
    
    
42. 
    Introduction for assorted cardiovascular topics II.
    Prog Cardiovasc Dis. 2022;74:1.
    PubMed    
    
    
    August 2022
43. LAVIE CJ
    Progress in Cardiovascular Diseases Statistics 2022.
    Prog Cardiovasc Dis. 2022 Aug 9. pii: S0033-0620(22)00087.
    PubMed    
    
    
    
44. LAVIE CJ
    Assorted Cardiovascular Topics 2022-Issue I Introduction.
    Prog Cardiovasc Dis. 2022 Aug 9. pii: S0033-0620(22)00088.
    PubMed    
    
    
    
45. JOSEPHSON RA, Lavie CJ
    Psychological distress in cardiovascular diseases and impact of cardiac rehabilitation programs.
    Prog Cardiovasc Dis. 2022 Aug 9. pii: S0033-0620(22)00086.
    PubMed    
    
    
    
46. AL RIFAI M, Yao J, Guo X, Post WS, et al
    Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis.
    Prog Cardiovasc Dis. 2022 Aug 8. pii: S0033-0620(22)00085.
    PubMed     Abstract available
    
    
    July 2022
47. SAYED A, Munir M, Awad K, Koltowski L, et al
    Are statins beneficial in patients with vasospastic angina? A meta-analysis of observational studies.
    Prog Cardiovasc Dis. 2022;73:88-90.
    PubMed    
    
    
    June 2022
48. IJAZ SH, Minhas AMK, Ghoneem A, Khan SU, et al
    Association of dementia with in-hospital outcomes in primary heart failure and acute myocardial infarction hospitalizations.
    Prog Cardiovasc Dis. 2022 Jun 16. pii: S0033-0620(22)00068.
    PubMed     Abstract available
    
    
    May 2022
49. ISATH A, Howard CE, Virani SS, Wang Z, et al
    Strength training and cardiovascular health: A meta-analysis.
    Prog Cardiovasc Dis. 2022 May 5. pii: S0033-0620(22)00044.
    PubMed    
    
    
    March 2022
50. KIANOUSH S, Al Rifai M, Patel J, George J, et al
    Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system.
    Prog Cardiovasc Dis. 2022;71:86-91.
    PubMed     Abstract available
    
    
    February 2022
51. POPOVIC D, Bjelobrk M, Tesic M, Seman S, et al
    Defining the importance of stress reduction in managing cardiovascular disease - the role of exercise.
    Prog Cardiovasc Dis. 2022 Feb 4. pii: S0033-0620(22)00015.
    PubMed     Abstract available
    
    
    
52. LAVIE CJ
    Nine years as editor-in chief of progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2022 Feb 1. pii: S0033-0620(22)00018.
    PubMed    
    
    
    January 2022
53. RAO S, Jamal T, Khan MS, Michos E, et al
    Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials.
    Prog Cardiovasc Dis. 2022 Jan 31. pii: S0033-0620(22)00005.
    PubMed     Abstract available
    
    
    
54. LUTZ AH, Forman DE
    Cardiac rehabilitation in older adults: Apropos yet significantly underutilized.
    Prog Cardiovasc Dis. 2022;70:94-101.
    PubMed     Abstract available
    
    
    
55. FRANKLIN BA, Quindry J
    High level physical activity in cardiac rehabilitation: Implications for exercise training and leisure-time pursuits.
    Prog Cardiovasc Dis. 2022;70:22-32.
    PubMed     Abstract available
    
    
    
56. HEINDL B, Ramirez L, Joseph L, Clarkson S, et al
    Hybrid cardiac rehabilitation - The state of the science and the way forward.
    Prog Cardiovasc Dis. 2022;70:175-182.
    PubMed     Abstract available
    
    
    
57. MAMATAZ T, Uddin J, Ibn Alam S, Taylor RS, et al
    Effects of cardiac rehabilitation in low-and middle-income countries: A systematic review and meta-analysis of randomised controlled trials.
    Prog Cardiovasc Dis. 2022;70:119-174.
    PubMed     Abstract available
    
    
    December 2021
58. KAMINSKY LA, German C, Imboden M, Ozemek C, et al
    The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease.
    Prog Cardiovasc Dis. 2021 Dec 16. pii: S0033-0620(21)00133.
    PubMed     Abstract available
    
    
    
59. FANAROFF AC, Lopes RD
    The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2021 Dec 6. pii: S0033-0620(21)00129.
    PubMed     Abstract available
    
    
    November 2021
60. ASSALI M, Buda KG, Megaly M, Hall AB, et al
    Update on chronic total occlusion percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2021 Nov 23. pii: S0033-0620(21)00123.
    PubMed     Abstract available
    
    
    
61. LAVIE CJ, Bernasconi A
    Impressive results with EPA, but EPA/DHA combinations also reduce cardiovascular outcomes.
    Prog Cardiovasc Dis. 2021 Nov 15. pii: S0033-0620(21)00121.
    PubMed    
    
    
    
62. OBRADOVIC D, Freund A, Feistritzer HJ, Sulimov D, et al
    Temporary mechanical circulatory support in cardiogenic shock.
    Prog Cardiovasc Dis. 2021;69:35-46.
    PubMed     Abstract available
    
    
    October 2021
63. SMITH JR, Taylor BJ
    Inspiratory muscle weakness in cardiovascular diseases: Implications for cardiac rehabilitation.
    Prog Cardiovasc Dis. 2021 Oct 21. pii: S0033-0620(21)00116.
    PubMed     Abstract available
    
    
    September 2021
64. MONTONE RA, Jang IK, Beltrame JF, Sicari R, et al
    The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries.
    Prog Cardiovasc Dis. 2021 Sep 30. pii: S0033-0620(21)00096.
    PubMed     Abstract available
    
    
    
65. LAVIE CC
    From the editor's desk-overweight and obesity and obesity paradox in cardiovascular diseases.
    Prog Cardiovasc Dis. 2021 Sep 23. pii: S0033-0620(21)00106.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.